In this paper, we confirmed that TP could alleviate SLE, and the mechanism of its efficacy may be elicited by affecting the differentiation of B cells into plasma cells by regulating miR-146a to inhibit the TLR7/NF-κB signaling pathway. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.